Flexion Therapeutics Current Cash

Flexion Therapeutics (FLXN) currently reports a current cash of $140M as of September 2021. That compares with $190M in the prior-year period — down 23.4% year over year. Use the charts on this page to explore Flexion Therapeutics's current cash history and peer comparisons.

Flexion Therapeutics's current cash decreased from $190M to $140M — a 23.4% year-over-year decrease (period ending September 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Flexion Therapeutics reported $140M in current cash as of September 2021. That compares with $190M in the prior-year period — down 23.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $140M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Flexion Therapeutics, and consider following FLXN for alerts when major investors trade the stock.

Flexion Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $140M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FLXN with unrelated industries.